scholarly journals Causes, comorbidities and current status of chronic kidney disease: A community perspective from North Kerala

2019 ◽  
Vol 8 (9) ◽  
pp. 2859 ◽  
Author(s):  
SabithaRose Jacob ◽  
Rini Raveendran ◽  
Suthanthira Kannan
2021 ◽  
pp. 183-215
Author(s):  
Yilin Zhang ◽  
Dongwei Liu ◽  
Zhangsuo Liu

AbstractThe impact of ambient particulate matter (PM) on public health has become a great global concern, which is especially prominent in developing countries. For health purposes, PM is typically defined by size, with the smaller particles having more health impacts. Particles with a diameter <2.5 μm are called PM2.5. Initial research studies have focused on the impact of PM2.5 on respiratory and cardiovascular diseases; nevertheless, an increasing number of data suggested that PM2.5 may affect every organ system in the human body, and the kidney is of no exception. The kidney is vulnerable to particulate matter because most environmental toxins are concentrated by the kidney during filtration. According to the high morbidity and mortality related to chronic kidney disease, it is necessary to determine the effect of PM2.5 on kidney disease and its mechanism that needs to be identified. To understand the current status of PM2.5 in the atmosphere and their potential harmful kidney effects in different regions of the world this review article was prepared based on peer-reviewed scientific papers, scientific reports, and database from government organizations published after the year 1998. In this review, we focus on the worldwide epidemiological evidence linking PM2.5 with chronic kidney disease and the effect of PM2.5 on the chronic kidney disease (CKD) progression. At the same time, we also discuss the possible mechanisms of PM2.5 exposure leading to kidney damage, in order to emphasize the contribution of PM2.5 to kidney damage. A global database on PM2.5 and kidney disease should be developed to provide new ideas for the prevention and treatment of kidney disease.


2011 ◽  
Vol 44 (11) ◽  
pp. 1077-1084
Author(s):  
Kenichiro Yasutake ◽  
Manami Nishiyama ◽  
Shihomi Motomura ◽  
Masaya Katayama ◽  
Osamu Rikitake ◽  
...  

2020 ◽  
Vol 25 (40) ◽  
pp. 4235-4250 ◽  
Author(s):  
Yu Dong ◽  
Xiaosheng Qu ◽  
Gang Wu ◽  
Xiangdong Luo ◽  
Botao Tang ◽  
...  

Chronic Kidney Disease (CKD) is characterized by the gradual loss of renal mass and functions. It has become a global health problem, with hundreds of millions of people being affected. Both its incidence and prevalence are increasing over time. More than $20,000 are spent on each patient per year. The economic burden on the patients, as well as the society, is heavy and their life quality worsen over time. However, there are still limited effective therapeutic strategies for CKD. Patients mainly rely on dialysis and renal transplantation, which cannot prevent all the complications of CKD. Great efforts are needed in understanding the nature of CKD progression as well as developing effective therapeutic methods, including pharmacological agents. This paper reviews three aspects in the research of CKD that may show great interests to those who devote to bioanalysis, biomedicine and drug development, including important endogenous biomarkers quantification, mechanisms underlying CKD progression and current status of CKD therapy.


BMJ ◽  
2017 ◽  
pp. j1420 ◽  
Author(s):  
Anoop Misra ◽  
Nikhil Tandon ◽  
Shah Ebrahim ◽  
Naveed Sattar ◽  
Dewan Alam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document